Defective P2Y Purinergic Receptor Function: A Possible Novel Mechanism for Impaired Glucose Transport

Journal of Cellular Physiology

Volumn 197, Issue 3, 2003, Pages 435-444

  Solini, Anna ^a   Chiozzi, Paola ^c   Morelli, Anna ^c   Passaro, Angela ^b   Fellin, Renato ^b   Di Virgilio, Francesco ^c,d  

^a UNIVERSITY OF PISA   (Italy)

^b Section of Internal Medicine   (Italy)

^c Section of General Pathology   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; APYRASE; DEOXYGLUCOSE; GLUCOSE; GLUCOSE TRANSPORTER 1; HEXOKINASE; MEMBRANE RECEPTOR; PURINE P2Y RECEPTOR;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL FUNCTION; CELL MEMBRANE; CELL MEMBRANE DEPOLARIZATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; FIBROBLAST; FLUOROMETRY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOSINE TRIPHOSPHATE; APYRASE; BIOLOGICAL TRANSPORT; CALCIUM; CALCIUM SIGNALING; CELL MEMBRANE; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; EXTRACELLULAR FLUID; FIBROBLASTS; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; HEXOKINASE; HUMANS; INSULIN RESISTANCE; MEMBRANE POTENTIALS; MONOSACCHARIDE TRANSPORT PROTEINS; RECEPTORS, PURINERGIC P2; RNA, MESSENGER;

EID: 0344825901     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10379     Document Type: Article

References (54)

1. Abraham EH, Prat AG, Gerweck L, Seneveratne T, Arceci RJ, Kramer R, Guidotti G, Cantiello HF. 1993. The multidrug resistance (mdrl) gene product functions as an ATP channel. Proc Natl Acad Sci USA 90:312-316.
2. Asano T, Wakisaka M, Yoshinari M, Nakamura S, Doi Y, Fujishima M. 2000. Troglitazone enhances glycolysis and improves intracellular glucose metabolism in rat mesangial cells. Metabol 49:308-313.
3. Baricordi OR, Ferrari D, Melchiorri L, Chiozzi P, Hanau S, Chiari E, Rubini M, Di Virgilio F. 1996. An ATP-activated channel is involved in mitogenic stimulation of human lymphocytes. Blood 87:682-690.
4. Baricordi OR, Melchiorri L, Adinolfi E, Falzoni S, Chiozzi P, Buell G, Di Virgilio F. 1999. Increased proliferation rate of lymphoid cells transfected with the P2X7 ATP receptor. J Biol Chem 274:33206-33208.
5. Bilan PJ, Mitsumoto Y, Ramlal T, Klip A. 1992. Acute and long-term effects of insulin-like growth factor I on glucose transporters in muscle cells. Translocation and biosynthesis. FEBS Lett 298:285-290.
6. Bodin P, Burnstock G. 2001. Purinergic signalling: ATP release. Neurochem Res 26:959-969.
7. Brady MJ, Saltiel AR. 1999. Closing in on the cause of insulin resistance and type 2 diabetes. J Clin Invest 104:675-676.
8. Burnstock G. 1997. The past, present and future of purine nucleotides as signalling molecules. Neuropharmacology 36:1127-1140.
9. Burnstock G. 1999. Current status of purinergic signalling in the nervous system. Prog Brain Res 120:3-10.
10. Busik JV, Olson LK, Grant MB, Henry DN. 2002. Glucose-induced activation of glucose uptake in cells from the inner and outer blood-retinal barrier. Invest Ophthalmol Vis Sci 43:2356-2363.
11. Cattaneo M, Lecchi A, Randi AM, McGregor JL, Mannucci PM. 1992. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood 80:2787-2796.
12. Coco S, Calegari F, Pravettoni E, Pozzi D, Taverna E, Rosa P, Matteoli M, Verderio C. 2003. Storage and release of ATP from astrocytes in culture. J Biol Chem 278:1354-1362.
13. Cohn ZA, Parks E. 1967. The regulation of pinocytosis in mouse macrophages III. The induction of vesicle formation by nucleoside and nucleotides. J Exp Med 125:457-466.
14. Cotrina M, Lin JH, Alves-Rodrigues A, Liu S, Li J, Azmi-Ghadimi H, Kang J, Naus CCG, Nedergard M. 1998. Connexin regulate calcium signaling by controlling ATP release. Proc Natl Acad Sci USA 95:15735-15740.
15. 2+ signalling in L-fibroblasts overexpressing type 1 inositol 1,4,5-trisphosphate receptors. Biochem J 341:813-820.
16. Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, Morelli A, Torboli M, Bolognesi G, Baricordi OR. 2001. Nucleotide receptors: An emerging family of regulatory molecules in blood cells. Blood 97:587-600.
17. Dixon CJ, Bowler WB, Littlewood-Evans A, Dillon JP, Bilbe G, Sharpe GR, Gallagher JA. 1999. Regulation of epidermal homeostasis through P2Y2 receptors. Br J Pharmacol 127:1680-1686.
18. Ebeling P, Koistinen HA, Koivisto VA. 1998. Insulin-independent glucose transport regulates insulin sensitivity. FEBS Lett 436:301-303.
19. Enjyoji K, Sevigny J, Lin Y, Frenette PS, Christie PD, Esch JS II, Imai M, Edelberg JM, Rayburn H, Lech M, Beeler DL, Csizmadia E, Wagner DD, Robson SC, Rosenberg RD. 1999. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 5:1010-1017.
20. Falcone M, Sarvetnick N. 1999. The effect of local production of cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Clin Immunol 90:2-9.
21. Falzoni S, Munerati M, Ferrari D, Spisani S, Moretti S, Di Virgilio F. 1995. The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. J Clin Invest 95:1207-1216.
22. Ferrari D, Chiozzi P, Falzoni S, Hanau S, Di Virgilio F. 1997. Purinergic modulation of interleukin-1β release from microglial cells stimulated with bacterial endotoxin. J Exp Med 185:579-582.
23. Fischer Y, Becker C, Loken C. 1999. Purinergic inhibition of glucose transport in cardiomyocytes. J Biol Chem 274:755-761.
24. Gaster M, Petersen J, Hojlund K, Poulsen P, Beck-Nielsen H. 2002. The diabetic phenotype is conserved in myotubes established for primary defects in glucose transport and glycogen synthase activity. Diabetes 51:921-927.
25. Gerich JE, Meyer C, Woerie HJ, Stumvoll M. 2001. Renal gluconeogenesis: Its importance in human glucose homeostasis. Diabetes Care 24:382-391.
26. Gherzi R, Meioli G, de Luca M, D'Agostino A, Distefano G, Guastelia M, D'Anna F, Franzi AT, Cancedda R. 1992. HepG2/erythroid/brain type glucose transporter (GLUT1) is highly expressed in human epidermis: Keratinocyte differentiation affects GLUT1 levels in recostituted epidermis. J Cell Physiol 150:463-474.
27. Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurden P, Julius D, Conley PB. 2001. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409:202-207.
28. Homolya L, Watt WC, Lazarowski ER, Koller BH, Boucher RC. 1999. Nucleotide-regulated calcium signalling in lung fibroblasts and epithelial cells from normal and P2Y(2) receptor (-/-) mice. J Biol Chem 274:26454-26460.
29. Hu XJ, Peng F, Zhou HO, Zhang ZH, Cheng WY, Feng HF. 2000. The abnormality of glucose transporter in the erythrocyte membrane of Chinese type 2 diabetic patients. Biochim Biophys Acta 1466:306-314.
30. Joseph SM, Buchakjian MR, Dubyak GR. 2003. Colocalization of ATP release sites and ecto-ATPase activity at the extracellular surface of human astrocytes. J Biol Chem 278:23331-23342.
31. Kitagawa T, Masumi A, Akamatsu Y. 1991. Transforming growth factor-beta 1 stimulates glucose uptake and the expression of glucose transporter mRNA in quiescent Swiss mouse 3T3 cells. J Biol Chem 266:18066-18071.
32. Klip A, Li G, Logan WJ. 1984. Induction of sugar uptake in response to insulin by serum depletion in fusing L6 myoblasts. Am J Physiol 247:E291-E296.
33. Klip A, Tsakiridis T, Marette A, Oritz P. 1994. Regulation of expression of glucose transporter by glucose: A review of studies in vivo and in cell culture. FASEB J 8:43-53.
34. Lazarowski ER, Harden TK. 1999. Quantitation of extracellular UTP using a sensitive enzymatic assay. Br J Pharmacol 127:1272-1278.
35. Maroto R, Hamil OP. 2001. Brefeldin A block of integrin-dependent mechanosensitive ATP release from Xenopous oocytes reveals a novel mechanism of mechanotransduction. J Biol Chem 276:23867-23872.
36. Martin MW, Harden TK. 1989. Agonist-induced desensitization of a P2Y-purinergic receptor-regulated phospholipase C. J Biol Chem 264:19535-19539.
37. Mc Gowan KM, Police S, Winslow JB, Pekala PH. 1997. Tumor necrosis factor-alpha regulation of glucose transporter (GLUT1) mRNA turnover. Contribution of the 3′-untranslated region of the GLUT1 message. J Biol Chem 272:1331-1337.
38. Meyer C, Stumvoll M, Dostou J, Welle S, Haymond M, Gerich J. 2002. Renal substrate exchange and gluconeogenesis in normal postabsorptive humans. Am J Physiol Endocrinol Metab 282:E428-E434.
39. Miele C, Formisano P, Condorelli G, Caruso M, Oriente F, Andreozzi F, Tocchetti CG, Riccardi G, Beguinot F. 1997. Abnormal glucose transport and GLUT 1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects. Diabetologia 40:421-429.
40. Mills DC. 1996. ADP receptors on platelets. Thromb Haemost 76:835-856.
41. Mulryan K, Gitterman DP, Lewis CJ, Vial C, Leckie BJ, Cobb AL, Brown JE, Conley EC, Buell G, Pritchard CA, Evans RJ. 2000. Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature 403:86-89.
42. 2+ response mediated by P2U and P2Y purinoceptors in human macrophages: Signalling from dying cells to macrophages. Immunology 98:220-227.
43. Ostrom RS, Gregorian C, Insel PA. 2000. Cellular release of and response to ATP as key determinants of the set point of signal transduction pathways. J Biol Chem 275:11735-11739.
44. Perregaux D, Gabel C. 1994. Interleukin 1 release in response to ATP and nigericin. J Biol Chem 269:15195-15203.
45. (2+)] modulates basal GLUT1 activity and plays a permissive role in its activation by metabolic stress and insulin in rat epithelial cells. Cell Calcium 28:97-106.
46. Ralevic V, Burnstock G. 1998. Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492.
47. Romanello M, Pani B, Bicego M, Di Andrea P. 2001. Mechanically induced ATP release from human osteoblastic cells. Biochem Biophys Res Commun 289:1275-1281.
48. Rump LC, Oberhauser V, von Kugelgen I. 1998. Purinoceptors mediate renal vasodilation by nitric oxide dependent and independent mechanisms. Kidney Int 54:473-481.
49. Solini A, Chiozzi P, Morelli A, Fellin R, Di Virgilio F. 1999. Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release. J Cell Sci 112:297-305.
50. 7 receptor-mediated function in human primary fibroblasts. Diabetologia 43:1248-1256.
51. Storz P, Doppler H, Wernig A, Pfizenmaier K, Muller G. 1999. Cross-talk mechanisms in the development of insulin resistance od skeletal muscle cells palmitate rather than tumor necrosis factors inhibits insulin-dependent protein kinase b (PKB)/Akt stimulation and glucose uptake. Eur J Biochem 266:17-25.
52. Verhey KJ, Birnbaum MJ. 1994. A Leu-Leu sequence is essential for COOH-terminal targeting signal of GLUT4 glucose transporter in fibroblasts. J Biol Chem 269:2353-2356.
53. Watson RT, Pessin JE. 2001. Intracellular organization of insulin signaling and GLUT4 translocation. Recent Prog Horm Res 56:175-193.
54. Yudkin JS, Stehouwer CD, Emei JJ, Coppack SW. 1999. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction - A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19:972-978.